Faculdade de Farmácia da Universidade de Lisboa

Faculdade de Farmácia da Universidade de Lisboa is a university in Lisboa, Portugal that has taken part in 26 EU-funded projects since 2015, receiving €5.2M in EU funding and leading 1 as coordinator.

EU funding received€5.2M
EU projects26
As coordinator1
Running now18
First EU project2015
Latest project2027
CountryPortugal
EU registration (PIC)993640065
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Faculdade de Farmácia da Universidade de Lisboa's own share of each project, not the project's full budget.

  • Horizon Europe€4.3M · 18 projects
  • Horizon 2020€844k · 6 projects
  • EU4Health Programme (EU4H)€107k · 1 project
  • Neighbourhood, Development and International Cooperation Instrument – Global Europe (NDICI)€43k · 1 project

Projects

26 EU-funded projects, newest first. Faculdade de Farmácia da Universidade de Lisboa led 1 of them as coordinator. Each links to the official record.

  • Vax4eUPartner

    Vaccinologists for Europe: Training network for developing next generation vaccines against mucosal pathogens

    Horizon Europe · 2027–2031 · Project on CORDIS ↗

    €279ktheir share
  • guideSkinPartner

    Bridging regulatory science and innovation for dermal generics and advanced skin therapies

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €559ktheir share
  • HEALSAFEPartner

    Health-Active Responsive Materials: Development, Stability, Safety, and Fate Evaluation in Complex Biological Media

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €150ktheir share
  • EXCEL-PHARMPartner

    Enhancing Postgraduate Excellence in Pharmaceutical and Health Sciences through Intra-African Mobility

    Neighbourhood, Development and International Cooperation Instrument – Global Europe (NDICI) · 2026–2029 · Project on the EU portal ↗

    €43ktheir share
  • PACEPartner

    Path to equity: expanding Access to cancer-preventing vaccination for adults and juveniles in European carceral settings

    EU4Health Programme (EU4H) · 2025–2028 · Project on the EU portal ↗

    €107ktheir share
  • LowDataMLAssociated partner

    Low Data Machine Learning for Sustainable Chemical Sciences

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • TIMNanoPartner

    RESTORING IMMUNITY CONTROL OF GI CANCERS

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

    €414ktheir share
  • CT-LusoPartner

    Ethics and Regulatory Capacity Building Partnership for Clinical Trials in Portuguese-speaking African Countries

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

  • STRIMHealthPartner

    Strengthening Translational Research for Improved Metabolic Health

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €232ktheir share
  • IMPULSEPartner

    IMProving User experience, Long-term sustainability and Services of EU-OPENSCREEN

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €114ktheir share
  • SIMPATHICPartner

    Accelerating drug repurposing for rare neurological, neurometabolic and neuromuscular disorders by exploiting SIMilarities in clinical and molecular PATHology

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €285ktheir share
  • Vax2MucPartner

    NEXT GENERATION VACCINES AGAINST GASTROINTESTINAL MUCOSAL PATHOGENS, USING HELICOBACTER PYLORI AS MODEL PATHOGEN

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €343ktheir share
  • FUNAMBULISTPartner

    FUnctional Nucleic Acids as Versatile SMart BUilding BLocks in Non-ConventIonal SolvenTs

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €372ktheir share
  • TClock4ADPartner

    Targeting Circadian Clock Dysfunction in Alzheimer’s Disease

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €243ktheir share
  • ISOBIOTICSAssociated partner

    Isotopic Labeling of Biotherapeutics

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

  • Fragment-ScreenPartner

    From fragments to high affinity binders interfacing integrated structural biology, medicinal chemistry and artificial intelligence

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €253ktheir share
  • More-EUROPAPartner

    More Effectively Using Registries to suppOrt PAtient-centered Regulatory and HTA decision-making

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €365ktheir share
  • halt-RONINPartner

    Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €401ktheir share
  • OncoProToolsPartner

    Protease‐guided tumor targeting tools to revolutionize cancer diagnosis and treatment.

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €243ktheir share
  • STOP SPREAD BAD BUGSAssociated partner

    STOP SPREAD BAD BUGS: novel antimicrobial approaches to combat multidrug resistance in bacteria

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

  • UNITE.H2020Associated partner

    Planning the Future of Research & Innovation in the European University Alliance UNITE!

    Horizon 2020 · 2021–2023 · Project on CORDIS ↗

  • Biomass4SynthonsCoordinator

    Straightening training, research and innovation capacities in the valorization of bio-renewable resource

    Horizon 2020 · 2021–2024 · Project on CORDIS ↗

    €293ktheir share
  • LITMUSPartner

    Liver Investigation: Testing Marker Utility in Steatohepatitis

    Horizon 2020 · 2017–2024 · Project on CORDIS ↗

    €57ktheir share
  • mtFOIE GRASPartner

    mitoFOIE GRAS: Non-invasive Profiling of Mitochondrial Function in Non-Alcoholic Fatty Liver Disease

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €18ktheir share
  • Foie GrasPartner

    Bioenergetic Remodeling in the Pathophysiology and Treatment of Non-Alcoholic Fatty Liver Disease

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

    €238ktheir share
  • ProteinConjugatesPartner

    A training network for the chemical site-selective modification of proteins: Preparation of the next-generation of therapeutic chemically-defined protein conjugates

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €238ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • antibiotic resistance
  • antibiotics
  • artificial intelligence
  • bacteriology
  • biocatalysis
  • biomaterials
  • biomolecules
  • business models
  • carbohydrates
  • cells technologies
  • chemical process engineering
  • computational intelligence
  • diabetes
  • drug discovery

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime